COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 391.7 | 4 | 0020-0251 | 61.22 | 251.90 | 222 | 54.77 | 0.930 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 512.5 | 4 | 0021-0252 | 929.07 | 252.31 | 258 | 60.77 | 0.878 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 386.4 | 4 | 0022-0261 | 757.81 | 261.64 | 281 | 65.01 | 0.835 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 405.3 | 4 | 0023-0260 | 858.20 | 260.13 | 218 | 61.70 | 0.720 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 427.0 | 4 | 0024-0273 | 154.52 | 273.23 | 239 | 64.53 | 0.721 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 378.2 | 4 | 0025-0274 | 848.11 | 274.54 | 288 | 65.94 | 0.832 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 648.7 | 4 | 0026-0278 | 57.57 | 278.85 | 196 | 52.53 | 0.893 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 485.2 | 4 | 0027-0290 | 821.95 | 289.82 | 232 | 58.53 | 0.851 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 359.5 | 4 | 0028-0297 | 30.71 | 296.88 | 302 | 66.77 | 0.851 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 499.5 | 4 | 0029-0300 | 383.48 | 300.35 | 174 | 49.11 | 0.907 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 443.6 | 4 | 0030-0308 | 258.64 | 308.85 | 209 | 57.60 | 0.792 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 371.7 | 4 | 0031-0310 | 101.43 | 310.42 | 257 | 62.53 | 0.826 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 406.6 | 4 | 0032-0312 | 542.78 | 311.58 | 301 | 68.77 | 0.800 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 450.5 | 4 | 0033-0325 | 554.36 | 324.38 | 243 | 67.01 | 0.680 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 462.7 | 4 | 0034-0343 | 635.95 | 342.84 | 195 | 59.01 | 0.704 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 591.1 | 4 | 0035-0351 | 370.80 | 351.24 | 187 | 53.70 | 0.815 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 372.8 | 4 | 0036-0350 | 928.55 | 349.11 | 162 | 51.94 | 0.755 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 366.8 | 4 | 0037-0355 | 938.44 | 356.34 | 139 | 44.28 | 0.891 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 421.1 | 4 | 0038-0361 | 218.64 | 361.70 | 202 | 57.11 | 0.778 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 584.8 | 4 | 0039-0373 | 278.48 | 373.34 | 189 | 51.46 | 0.897 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 800.6 | 4 | 0040-0382 | 801.04 | 382.03 | 194 | 55.70 | 0.786 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 397.0 | 4 | 0041-0388 | 284.57 | 388.10 | 256 | 62.53 | 0.823 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 425.5 | 4 | 0042-0391 | 415.82 | 392.06 | 295 | 67.36 | 0.817 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 398.1 | 4 | 0043-0390 | 53.66 | 390.17 | 240 | 60.18 | 0.833 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 385.5 | 4 | 0044-0393 | 267.09 | 393.23 | 290 | 67.26 | 0.806 |